Skip to main content
Loading
Daniel Haders II, Ph.D, - Model Medicines

Daniel Haders II, Ph.D,

CEO, Model Medicines

Dr. Daniel Haders is the Co-Founder and CEO of Model Medicines, an AI-driven therapeutics company advancing novel drug candidates like MDL-001. Under his leadership, the company has raised over $14M from top investors and earned recognition from Fierce Medtech, GEN, and GreyB. Named one of the "Top 50 Healthcare AI Entrepreneurs of 2025" by The Great Entrepreneurs and featured in Bloomberg’s "Vanguards of Healthcare" series, Dr. Haders previously led a top-ranked Digital Health Accelerator, investing in 25+ startups. He has held senior roles in biotech, secured FDA approval for CEQUA, and holds a BS and PhD in Biomedical Engineering.

Sessions